NEC Orchestrating Future Fund Announces Strategic Investment in Aetion
- Editor
- Feb 18
- 1 min read
Whats Happening:
NEC Orchestrating Future Fund (NOFF), a corporate venture capital fund established by NEC Corporation, has invested in Aetion, a global leader in real-world evidence technology and analytics. The two companies are collaborating to use real-world data from Japanese electronic health records on Aetion's platform to advance drug development in Japan and globally.
Key Moves:
NOFF invests in Aetion, a leader in real-world evidence technology
NEC and Aetion collaborate to use Japanese health data for drug development
Aetion's platform to be used for analyzing real-world healthcare data in Japan
By The Numbers:
NEC has provided IT services to hospitals for over 50 years
Aetion's platform enables rapid and transparent answers on medical interventions
NEC aims to address medical and healthcare challenges through its healthcare business
Key Quotes:
"As Aetion redefines how healthcare organizations make critical decisions with enterprise-grade technology, this investment from NOFF demonstrates their vision of how our software can help decision makers in Japan and beyond," said Jeremy Rassen, CEO of Aetion.
"Together with Aetion, we will accelerate our efforts to create new social value," said Shigeki Wada, corporate senior vice president of NEC Corporation.
Bottom Line:
The strategic investment and collaboration between NEC's venture fund and Aetion aims to leverage Japanese healthcare data for global drug development. This partnership has the potential to improve drug development efficiency, streamline regulatory approvals, and create new treatment methods by utilizing real-world evidence technology.
Comments